Ildong Lapatidine Tablet 10 mg

Adult dosage

1. Short-term treatment of gastric ulcers: The usual dose is lafutidine 10mg orally twice daily, in the morning and at bedtime. In clinical trials with treatment for up to 8 weeks, most ulcers healed within 8 weeks; however, healing time may occasionally vary among patients. 2. Short-term treatment of duodenal ulcers: The usual dose is lafutidine 10mg orally twice daily, in the morning and at bedtime. In clinical trials with treatment for up to 6 weeks, most ulcers healed within 6 weeks; however, healing time may occasionally vary among patients. 3. Improvement of gastric mucosal lesions in acute gastritis and chronic gastritis: The usual dose is lafutidine 10mg orally once daily at bedtime. In clinical trials with treatment for up to 2 weeks, most lesions healed within 2 weeks; however, healing time may occasionally vary among patients. 4. Combination therapy with antibiotics for patients with peptic ulcers infected with Helicobacter pylori: Administer lafutidine 20mg, clarithromycin 500mg, and amoxicillin 1000mg twice daily for 7 or 14 days. 5. Premedication for anesthesia: The usual dose is lafutidine 10mg per dose, given twice orally (at bedtime on the day before surgery and 2 hours before anesthesia on the day of surgery). 6. Treatment of reflux esophagitis: Administer lafutidine 10mg per dose twice orally.

This medication should not be administered to patients who are allergic to certain components. It contains lactose, so caution is necessary for patients with lactose intolerance or specific genetic conditions. Patients allergic to soybean oil, soy, peanuts, etc., should avoid using this medication. Patients who have had hypersensitivity reactions to medications, those with impaired liver or kidney function, patients undergoing dialysis, the elderly, and those with abnormalities in lipid metabolism should use it cautiously. This medication can rarely cause serious allergic reactions, liver dysfunction, or reduction of blood cells, so consult a healthcare provider immediately if symptoms occur. Mild side effects such as headache, dyspepsia, nausea, constipation may also occur, so careful monitoring is necessary. In cases where malignant tumors are suspected, tests must be performed before using this medication, and if diagnosed with gastric cancer, use should be discontinued. If there is no therapeutic effect, it is recommended to switch to other treatment methods. Patients at risk of lipid overload should regularly check blood lipid levels and adjust medication dosages. Elderly patients should be attentive to dosages and frequency of administration due to declining body functions. For patients undergoing dialysis, high blood concentrations may occur, so it should be started cautiously at a low dose. Pregnant women should only be administered if deemed necessary by a physician, and it is safer for breastfeeding women not to take this medication. Safety in children has not been sufficiently confirmed, so caution is needed for use. This medication should be kept out of reach of children and stored in its original container for safety.

• Shock
• anaphylaxis symptoms
• facial pallor
• hypotension
• generalized rash
• dyspnea
• liver dysfunction
• jaundice
• agranulocytosis
• pharyngitis

This medication should be stored in a tightly closed container to protect it from air and moisture. It is important to maintain a storage temperature between 1 degree and 30 degrees Celsius. Proper storage helps maintain the medication's efficacy and safety.

Appearance

White round film-coated tablet

Package unit

30 tablets/bottle, 300 tablets/bottle